StockpollyBeta
Get App
Delisting riskPopularity #3,845
LAB · NASDAQ · Medical - Specialties

Standard BioTools (LAB)

Sells retained mass-cytometry and microfluidic genomics systems after the SomaScan sale.

$0.7498
After hours+0.00 (+0.04%)
At close$0.7495(+1.02%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue252846224547202220242120
Cost of revenue14152112222591110141010
Gross profit11132410232211119101111
323584415555353433322136
Research & development671671314566822
222147253438302827241916
General & administrative0000000000016
Other expenses46219730000018
Operating income−21−21−60−30−32−33−24−24−23−22−9−25
012855−115−90−54
Interest income006540322240
Interest expense111100000000
Other non-operating income−4−3−29−6−7−3−1−59054
Income before tax−21−20−32−25−27−34−23−18−33−22−15−21
Income tax expense0000000−1−1−3600
Net income from continuing operations−21−20−32−25−27−34−23−18−3214−15−22
Discontinued operations000−2000−3−16−35−31−5
Net income−21−20−32−46−27−34−26−33−3519−45−27
EPS, basic−$0.27−$0.25−$0.27−$0.12−$0.07−$0.09−$0.07−$0.09−$0.09$0.05−$0.12−$0.07
EPS, diluted−$0.27−$0.25−$0.27−$0.12−$0.07−$0.09−$0.07−$0.09−$0.09$0.05−$0.12−$0.07
Weighted average shares, basic7980294372372375378380383385388391
Weighted average shares, diluted7980294372372375378380383385388391
EBITDA−14−15−26−21−20−26−19−16−31−21−13−27
Depreciation & amortization445444422113
EBIT−18−19−31−25−24−30−23−18−33−22−15−29